Core Viewpoint - Rosen Law Firm is reminding investors who purchased agilon health, inc. securities between February 26, 2025, and August 4, 2025, of the March 2, 2026, deadline to become a lead plaintiff in a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased agilon securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court by March 2, 2026, to serve as lead plaintiff, representing other class members [3]. - The lawsuit alleges that defendants made false and misleading statements regarding agilon's financial guidance and the impact of strategic actions taken to reduce risk, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting that many firms issuing notices may lack relevant experience [4]. - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company, and has consistently ranked highly in securities class action settlements since 2013 [4]. - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [4].

Core Insights - The "Digital Intelligent Rehabilitation Platform for Full Course" project from Guiyang Second People's Hospital has been awarded the "2025 Provincial Demonstration Project for Digital Livelihood" due to its innovative strength and value for people's livelihoods [1] - The platform has been recognized as a national-level smart rehabilitation project, being the only one approved in Guizhou province by the Ministry of Industry and Information Technology and the National Health Commission [1] Group 1: Platform Features and Innovations - The platform utilizes artificial intelligence, 5G communication, and IoT technology to break traditional barriers in rehabilitation healthcare, creating a three-tier service system: "hospital-community-home" [2] - AI assessments can complete a comprehensive analysis of patient movement trajectories in just 3 minutes, achieving over 90% accuracy in agreement with experienced physicians, and improving assessment efficiency by over 300% compared to traditional methods [2] - The platform offers seamless integration of "hospital diagnosis-home rehabilitation-remote guidance," allowing patients to initiate personalized home rehabilitation training via mobile apps or TV screens, with real-time monitoring and dynamic optimization of training plans [2] Group 2: Impact and Achievements - Since its launch, the platform has served nearly 1,400 patients and conducted over 1,700 AI assessments, with an average improvement rate of 30% in limb function for patients who have used the service for more than six months [2] - The operational efficiency of the hospital departments has increased by 20%, fulfilling the commitment to reduce costs without compromising quality [2] Group 3: Future Plans - The hospital aims to deepen the construction of the digital rehabilitation ecosystem by integrating more medical institutions into the platform, thereby benefiting a wider population [3] - There will be a focus on technical collaboration with authoritative institutions to continuously optimize rehabilitation algorithms and training program libraries, enhancing the platform's intelligence and clinical adaptability [3] - Talent cultivation will be strengthened through specialized research and skills training, aiming to develop composite talents in the field of digital rehabilitation [3]

Core Points - Rep. Julia Letlow reportedly violated the STOCK Act by failing to disclose 224 stock and bond trades within the required 45-day reporting window [2][5] - The value of these trades ranges between $225,000 and $3.3 million, including shares of major companies like Alphabet, Amazon, Apple, and Meta [3][4] - Letlow's office acknowledged the violation, stating that the trades were managed by Merrill Lynch without her direct involvement [5] Legislative Context - Letlow's delayed disclosures occur amid a bipartisan effort to ban Congress members and their families from trading individual stocks, highlighted by the introduction of the Restore Trust in Congress Act [6] - The STOCK Act, signed into law in 2012, mandates that Congress members disclose transactions over $1,000 within 45 days, with penalties for violations [7]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - Investors who purchased Agilon securities between February 26, 2025, and August 4, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 2, 2026 [3]. - The lawsuit alleges that Agilon's management made false and misleading statements regarding the company's financial guidance and strategic actions, which led to investor damages when the truth was revealed [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success in recovering hundreds of millions for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, achieving the largest settlement against a Chinese company and ranking highly in the number of settlements since 2013 [4].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Ardent Health, Inc. due to allegations of violations of federal securities laws related to misleading statements about the company's accounts receivable and professional malpractice liability insurance [2][5]. Group 1: Legal Investigation and Class Action - The firm is encouraging investors who suffered losses in Ardent between July 18, 2024, and November 12, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Ardent, with a deadline of March 9, 2026, for investors to seek the role of lead plaintiff [2]. - The complaint alleges that Ardent and its executives made false statements and failed to disclose critical information regarding the company's financials [5]. Group 2: Financial Impact and Stock Performance - On November 12, 2025, Ardent announced a $43 million reduction in revenue due to accounting changes and a $54 million increase in professional liability reserves [5]. - Following this announcement, Ardent's stock price fell by $4.75 per share, or 33.81%, closing at $9.30 per share on November 13, 2025 [6]. Group 3: Firm Background and Contact Information - Faruqi & Faruqi, LLP is a national securities law firm with a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Ardent's conduct [8].

Group 1: Robinhood Markets - Robinhood Markets has seen exceptional performance over the past two years, with significant revenue and earnings growth, but faces concerns about maintaining this momentum due to high valuation and reliance on cryptocurrency trading [3][4]. - The company's forward price-to-earnings ratio stands at 46.5, which is notably high compared to the average of 16.5 for financial stocks, raising questions about its valuation [3]. - Despite volatility in the crypto market, Robinhood's trading platform is popular among younger investors, and the company has expanded its services, including the launch of Robinhood Legend and AI trading tools, which could support future growth [6][7]. Group 2: HCA Healthcare - HCA Healthcare is positioned to benefit from demographic shifts, with projections indicating that older adults will outnumber younger individuals in the U.S. by 2035, leading to increased healthcare spending [9]. - The company operates a diverse network of facilities, including urgent care centers and hospitals, and has experienced strong performance due to higher demand and favorable reimbursement rates [10]. - HCA Healthcare faces reimbursement risks from potential changes in Medicare and Medicaid programs but manages this through a diversified payer mix, with approximately half of its revenue coming from commercial insurance [12].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Agilon Health, Inc. during the specified Class Period of the upcoming lead plaintiff deadline for a securities class action lawsuit [1]. Group 1: Class Action Details - The Class Period for the securities of Agilon Health, Inc. is from February 26, 2025, to August 4, 2025 [1]. - Investors who purchased Agilon securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and those wishing to serve as lead plaintiff must act by March 2, 2026 [3]. Group 2: Case Allegations - The lawsuit alleges that defendants made false and misleading statements and failed to disclose critical information, including that they issued guidance for 2025 that was unlikely to be achieved due to known industry challenges [5]. - It is claimed that the defendants overstated the immediate financial benefits from strategic actions taken by Agilon to mitigate risks, leading to materially false statements about the company's business and prospects [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been ranked highly for securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4].

Core Viewpoint - A securities class action lawsuit has been filed against Ardent Health, Inc. for failing to disclose material information during the class period, leading to significant financial losses for investors [3]. Group 1: Lawsuit Details - Investors who suffered substantial losses from purchasing Ardent's securities between July 18, 2024, and November 12, 2025, have until March 9, 2026, to file lead plaintiff applications [1]. - The lawsuit is pending in the United States District Court for the Middle District of Tennessee [1]. Group 2: Financial Impact - On November 12, 2025, Ardent disclosed a $43 million decrease in third quarter 2025 revenue due to revised determinations of accounts receivable collectability and recent evaluations of historical collection trends [4]. - The company cut its 2025 EBITDA guidance by approximately 9.6%, from a range of $575 million - $625 million to $530 million - $555 million, citing persistent industry-wide cost pressures [4]. - Ardent also recorded a $54 million increase in professional liability reserves related to recent settlements and ongoing litigation [4]. - Following this news, Ardent's share price fell by $4.75, or nearly 34%, from $14.05 to $9.30 per share on November 13, 2025, with unusually heavy trading volume [4]. Group 3: Legal Representation - Kahn Swick & Foti, LLC, a prominent securities litigation law firm, is representing the investors in this case [5]. - The firm has been recognized among the top 10 firms nationally based on total settlement value and serves a variety of clients seeking recoveries for investment losses due to corporate fraud [5].

NEW YORK, Jan. 16, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Ardent Health, Inc. (NYSE: ARDT) between July 18, 2024 and November 12, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 9, 2026. SO WHAT: If you purchased Ardent Health securities during the Class Period y ...

NEW YORK, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Ardent Health, Inc. (“Ardent” or the “Company”) (NYSE:ARDT) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost. If you suffered a loss on your Ardent investments, you have until March 9, 2026 to request lead plaintiff appointment. Follow th ...